CONTRACEPTION

This phase 3 trial compares a new combined oral contraceptive pill (estetrol-drospirenone) to a standard one (ethinylestradiol-levonorgestrel) in 98 women aged 18-49. Researchers will measure artery function, blood pressure, and metabolic markers over 12 months to see if the new …

This study compares two emergency contraception pills: levonorgestrel plus piroxicam (an anti-inflammatory drug) versus levonorgestrel alone. About 1,458 women aged 16-35 who had unprotected sex within 72 hours will participate. The goal is to see if adding piroxicam reduces preg…

This study is testing a new type of birth control: a copper vaginal ring that women insert themselves, like NuvaRing, but without hormones. The ring is meant to prevent pregnancy using copper, similar to a copper IUD but less invasive. Eight women will wear the ring for 28 days, …

This study looks at how to make HIV prevention pills (PrEP) easier for young people to get and keep using. Researchers will follow 1000 current or eligible PrEP users in Alabama and Botswana for 2 years. They will also create and test a decision-support toolkit to help patients a…

This study tests whether motivational interviewing, a type of counseling that helps people make their own health decisions, can improve attitudes and intentions toward modern birth control methods. The study will include 120 women in Turkey who currently use traditional methods l…

This study looks at how a long-acting injectable HIV prevention drug (CAB-LA) and hormonal birth control methods (like the shot or implant) affect each other in women. About 105 women who already use CAB-LA or no HIV prevention will join groups based on their contraceptive choice…

This study will test a program called "Mittin" to see if it helps women using birth control in Addis Ababa, Ethiopia, manage their fertility in a way that matches their personal preferences. About 2,715 women aged 15-49 from public health centers will either receive the Mittin pr…